Molecular analysis of surgical margins in head and neck cancer: More than a marginal issue

Oral Oncology

Volumn 46, Issue 7, 2010, Pages 485-491

  Braakhuis, Boudewijn J M ^a   Bloemena, Elisabeth ^a,b   Leemans, C René ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Head and neck cancer; Head and neck neoplasms; Local relapse; Molecular diagnosis; Mouth neoplasms; Oral cancer; Oral cavity; Pharynx; Recurrence; Relapse

Indexed keywords

NUCLEIC ACID;

CANCER CELL; CANCER RADIOTHERAPY; CANCER RISK; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; NUCLEIC ACID ANALYSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; TUMOR MARKERS, BIOLOGICAL;

EID: 77953361281     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.01.019     Document Type: Review

References (70)

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45 4-5 (2009) 309-316
2. Braakhuis B.J., Visser O., and Leemans C.R. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 45 9 (2009) e85-e89
3. Curado M.P., and Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21 3 (2009) 194-200
4. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., and Coebergh J.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 10 (2008) 1345-1389
5. Slootweg P.J., Hordijk G.J., Schade Y., Van Es R.J.J., and Koole R. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol 38 5 (2002) 500-503
6. Leemans C.R., Tiwari R., Nauta J.J., van der Waal I., and Snow G.B. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73 1 (1994) 187-190
7. Eckardt A., Barth E.L., Kokemueller H., and Wegener G. Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period. Oral Oncol 40 4 (2004) 427-432
8. Van Houten V.M.M., Tabor M.P., Van Den Brekel M.W.M., Kummer J.A., Denkers F., Dijkstra J., et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 198 4 (2002) 476-486
9. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., Kummer J.A., Leemans C.R., and Braakhuis B.J. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 10 11 (2004) 3607-3613
10. Tabor M.P., Brakenhoff R.H., van Houten V.M., Kummer J.A., Snel M.H., Snijders P.J., et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 7 6 (2001) 1523-1532
11. Rosin M.P., Cheng X., Poh C., Lam W.L., Huang Y., Lovas J., et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 6 2 (2000) 357-362
12. Partridge M., Pateromichelakis S., Phillips E., Emilion G., and Langdon J. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma. Clin Cancer Res 7 7 (2001) 1860-1866
13. Braakhuis B.J., Tabor M.P., Kummer J.A., Leemans C.R., and Brakenhoff R.H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63 8 (2003) 1727-1730
14. Braakhuis B.J., Tabor M.P., Leemans C.R., van der Waal I., Snow G.B., and Brakenhoff R.H. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24 2 (2002) 198-206
15. Van Houten V.M.M., Leemans C.R., Kummer J.A., Dijkstra J., Kuik D.J., Van Den Brekel M.W.M., et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res 10 11 (2004) 3614-3620
16. Woolgar J.A., and Triantafyllou A. A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. Oral Oncol 41 10 (2005) 1034-1043
17. Batsakis J.G. Surgical excision margins: a pathologist's perspective. Adv Anat Pathol 6 3 (1999) 140-148
18. Meier J.D., Oliver D.A., and Varvares M.A. Surgical margin determination in head and neck oncology: current clinical practice. The results of an international American head and neck society member survey. Head Neck 27 11 (2005) 952-958
19. Looser K.G., Shah J.P., and Strong E.W. The significance of positive margins in surgically resected epidermoid carcinomas. Head Neck Surg 1 2 (1978) 107-111
20. Mcmahon J., O'brien C.J., Pathak I., Hamill R., Mcneil E., Hammersley N., et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg 41 4 (2003) 224-331
21. Kovacs A.F. Relevance of positive margins in case of adjuvant therapy of oral cancer. Int J Oral Maxillofac Surg 33 5 (2004) 447-453
22. Gonzalez-Garcia R., Naval-Gias L., Roman-Romero L., Sastre-Perez J., and Rodriguez-Campo F.J. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients. Head Neck 31 9 (2009) 1168-1180
23. Bradford C.R., Wolf G.T., Fisher S.G., and Mcclatchey K.D. Prognostic importance of surgical margins in advanced laryngeal squamous carcinoma. Head Neck 18 1 (1996) 11-16
24. Cook J.A., Jones A.S., Phillips D.E., and Lluch E.S. Implications of tumor in resection margins following surgical-treatment of squamous-cell carcinoma of the head and neck. Clin Otolaryngol 18 1 (1993) 37-41
25. Sutton D.N., Brown J.S., Rogers S.N., Vaughan E.D., and Woolgar J.A. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32 1 (2003) 30-34
26. Binahmed A., Nason R.W., and Abdoh A.A. The clinical significance of the positive surgical margin in oral cancer. Oral Oncol 43 8 (2007) 780-784
27. Liao C.T., Chang J.T.C., Wang H.M., Ng S.H., Hsueh C., Lee L.Y., et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 15 3 (2008) 915-922
28. Nason R.W., Binahmed A., Pathak K.A., Abdoh A.A., and Sandor G.K.B. What is the adequate margin of surgical resection in oral cancer?. Oral Surg Oral Med O 107 5 (2009) 625-629
29. Brandwein-Gensler A., Teixeira M.S., Lewis C.M., Lee B., Rolnitzky L., Hille J.J., et al. Oral squamous cell carcinoma - histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29 2 (2005) 167-178
30. Kademani D., Bell R.B., Bagheri S., and Holmgren E. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg 63 11 (2005) 1599-1605
31. Schaaij-Visser T.B., Graveland A.P., Gauci S., Braakhuis B.J., Buijze M., Heck A.J., et al. Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res 15 24 (2009) 7666-7675
32. Sinha P., Bahadur S., Thakar A., Matta A., Macha M., Ralhan R., et al. Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck 31 11 (2009) 1423-1430
33. Weijers M., Snow G.B., Bezemer P.D., Van Der Wal J.E., and Van Der Waal I. The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients. J Oral Pathol Med 31 1 (2002) 11-15
34. Warnakulasuriya S., Reibel J., Bouquot J., and Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37 3 (2008) 127-133
35. Tabor M.P., Braakhuis B.J., van der Wal J.E., van Diest P.J., Leemans C.R., Brakenhoff R.H., et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol 199 3 (2003) 354-360
36. Bosman F.T. Dysplasia classification: pathology in disgrace?. J Pathol 194 2 (2001) 143-144
37. Voravud N., Shin D.M., Ro J.Y., Lee J.S., Hong W.K., and Hittelman W.N. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 53 12 (1993) 2874-2883
38. Barrera J.E., Ai H., Pan Z.X., Meyers A.D., and VarellaGarcia M. Malignancy detection by molecular cytogenetics in clinically normal mucosa adjacent to head and neck tumors. Arch Otolaryngol Head Neck Surg 124 8 (1998) 847-851
39. Izzo J.G., Papadimitrakopoulou V.A., Li X.Q., Ibarguen H., Lee J.S., Ro J.Y., et al. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene 17 18 (1998) 2313-2322
40. Stafford N.D., Ashman J.N., MacDonald A.W., Ell S.R., Monson J.R., and Greenman J. Genetic analysis of head and neck squamous cell carcinoma and surrounding mucosa. Arch Otolaryngol Head Neck Surg 125 12 (1999) 1341-1348
41. Jin X.J., Zhou L., and Zhao A.G. Mutants of p53 gene presence in laryngeal carcinoma and adjacent histopathologically normal tissue. ORL J Otorhinolaryngol 62 3 (2000) 140-142
42. Cruz I.B., Cjlm M., Snijders P.J.F., Snow G.B., Walboomers J.M.M., Van Der Waal I., et al. p53 Immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management. J Pathol 191 2 (2000) 132-137
43. Van Der Toorn P.P.G., Veltman J.A., Bot F.J., De Jong J.M.A., Manni J.J., Ramaekers F.C.S., et al. Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)malignant cells. J Pathol 193 1 (2001) 66-72
44. Ott C.E., Skroch E., Steinhart H., Verdorfer I., Pahl S., Iro H., et al. Thin section arrays for I-FISH analysis of chromosome-specific imbalances in squamous cell carcinomas of the head and neck. Int J Oncol 20 3 (2002) 623-630
45. Fabricius E.M., Gurr U., and Wildner G.P. Telomerase activity levels in the surgical margin and tumour distant tissue of the squamous cell carcinoma of the head-and-neck. Anal Cell Pathol 24 1 (2002) 25-39
46. Goldenberg D., Harden S., Masayesva B.G., Ha P., Benoit N., Westra W.H., et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 130 1 (2004) 39-44
47. Szukala K., Brieger J., Bruch K., Biczysko W., Wierzbicka M., Szyfter W., et al. Loss of heterozygosity on chromosome arm 13q in larynx cancer patients: analysis of tumor, margin and clinically unchanged mucosa. Med Sci Monitor 10 6 (2004) CR233-CR240
48. Preuss S.F., Brieger J., Essig E.K., Stenzel M.J., and Mann W.J. Quantitative DNA measurement in oropharyngeal squamous cell carcinoma and surrounding mucosa. ORL J Otorhinolaryngol 66 6 (2004) 320-324
49. Brieger J., Kastner J., Gosepath J., and Mann W.J. Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma. Cancer Genet Cytogenet 167 1 (2006) 26-31
50. Poh C.F., Zhang L., Anderson D.W., Durham J.S., Williams P.M., Priddy R.W., et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 12 22 (2006) 6716-6722
51. Szukala K., Sowinska A., Wierzbicka M., Biczysko W., Szyfter W., and Szyfter K. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?. Mutat Res 600 1-2 (2006) 67-76
52. Martone T., Gillio-Tos A., De Marco L., Fiano V., Maule M., Cavalot A., et al. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res 13 17 (2007) 5089-5094
53. Tunca B., Erisen L., Coskun H., Cecener G., Ozuysal S., and Egeli U. P53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck. Tumori 93 2 (2007) 182-188
54. Bremmer J.F., Braakhuis B.J.M., Brink A., Broeckaert M.A.M., Belien J.A.M., Meijer G.A., et al. Comparative evaluation of genetic assays to identify oral pre-cancerous fields. J Oral Pathol Med 37 10 (2008) 599-606
55. Bilde A., Von Buchwald C., Dabelsteen E., Therkildsen M.H., and Dabelsteen S. Molecular markers in the surgical margin of oral carcinomas. J Oral Pathol Med 38 1 (2009) 72-78
56. Graveland A.P., De Maaker M., Braakhuis B.J.M., De Bree R., Eerenstein S.E.J., Bloemena E., et al. Molecular detection of minimal residual cancer in surgical margins of head and neck cancer patients. Cell Oncol 31 4 (2009) 317-328
57. Pitiyage G., Tilakaratne W.M., Tavassoli M., and Warnakulasuriya S. Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med 38 10 (2009) 737-752
58. Brennan J.A., Mao L., Hruban R.H., Boyle J.O., Eby Y.J., Koch W.M., et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332 7 (1995) 429-435
59. Nathan C.A.O., Franklin S., Abreo F.W., Nassar R., DeBenedetti A., and Glass J. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J Clin Oncol 17 9 (1999) 2909-2914
60. Nathan C.A.O., Sanders K., Abreo F.W., Nassar R., and Glass J. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res 60 13 (2000) 3599-3604
61. Partridge M., Li S.R., Pateromichelakis S., Francis R., Phillips E., Huang X.H., et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 6 7 (2000) 2718-2725
62. Sardi I., Franchi A., Ferriero G., Frittelli A., Bruschini L., Montali E., et al. Prediction of recurrence by microsatellite analysis in head and neck cancer. Gene Chromosome Cancer 29 3 (2000) 201-206
63. Temam S., Casiraghi O., Lahaye J.B., Bosq J., Zhou X., Julieron M., et al. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma. Clin Cancer Res 10 12 (2004) 4022-4028
64. Handschel J., Oz D., Pomjanski N., Depprich R., Ommerborn M.A., Braunstein S., et al. Additional use of DNA-image cytometry improves the assessment of resection margins. J Oral Pathol Med 36 8 (2007) 472-475
65. Huang X., Pateromichelakis S., Hills A., Sherriff M., Lyons A., Langdon J., et al. P53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins. Clin Cancer Res 13 20 (2007) 6099-6106
66. Tan H.K., Saulnier P., Auperin A., Lacroix L., Casiraghi O., Janot F., et al. Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas. Br J Cancer 99 2 (2008) 357-363
67. Zhao H.Y., Ren J., Zhuo X.L., Ye H.P., Zou J., and Liu S.X. Prognostic significance of survivin and cd44v6 in laryngeal cancer surgical margins. J Cancer Res Clin Oncol 134 10 (2008) 1051-1058
68. Bergshoeff V.E., Hopman A.H., Zwijnenberg I.R., Ramaekers F.C., Bot F.J., Kremer B., et al. Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinoma. J Pathol 215 3 (2008) 347-348
69. Simon R.M., Paik S., and Hayes D.F. Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst 101 21 (2009) 1446-1452
70. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., Van Der Wal J.E., Snow G.B., Leemans C.R., et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 161 3 (2002) 1051-1060